 |
Endacea, Inc. - LEADERSHIP,
Summary Biographies
Constance Neely Wilson, M.D. - VP, Chief Scientific Officer; Founder and Director
 Dr.
Wilson is Endacea's Founder and the inventor of its
purinoceptor-based technologies. She is an endotoxin
scientist, a purinoceptor pharmacologist, and a board certified anesthesiologist
and critical care physician with strong expertise in cardiopulmonary medicine and 21 years experience in operating room anesthesia and surgical intensive care medicine at Massachusetts
General Hospital, Tulane Medical Center, and the Hospital
of the University of Pennsylvania. She has discovered
a body of science and medicine, focused on the A1 adenosine
receptor, to diagnose and treat sepsis,
to treat reperfusion organ injury associated
with cardiopulmonary bypass surgery and transplantation,
and to treat a number of other diseases, including asthma
and cancer. She has also discovered important uses for P2X purinoceptor antagonists to treat reperfusion organ injury, fibrosis and sclerosis, and HIV/AIDS.
Dr. Wilson is an active researcher with
over $4 million in grants awarded, mostly from the National Institutes
of Health. She has authored or co-authored many original
manuscripts, abstracts, and chapters. Dr. Wilson is the invited Senior Editor of the next volume of the Handbook of Experimental Pharmacology, "Adenosine Receptors in Health and Disease." She is the inventor
of fifteen issued U.S. patents, eight pending U.S. patent applications, and eighteen issued or allowed international
patents. Dr. Wilson received
her M.D. degree from the University of Virginia in 1974 and
her B.S. in chemistry from Madison College in 1970. Prior to September 2000, her name was Constance Fisher Neely.
Donald H. Wilson, III, President, CEO, and General Counsel; Director and Investor
 Mr.
Wilson has raised $4.3 million in equity, $1.5 million
in convertible debt, and $0.6 million in debt financing for Endacea. As Endacea's principal
business and legal officer, he negotiates licenses, sponsored
research agreements, financing agreements and other contracts, and manages relationships
with investors.
Mr. Wilson was the Founder and CEO of
MWI Training Services, Inc., a 1996 Inc.
500 company. He sold MWI to Global Knowledge Network,
Inc., a roll-up owned by Welsh, Carson, Anderson & Stowe in a profitable exit.
Previously, Mr. Wilson advised diverse international
clients as a Management Consultant for the Boston Consulting
Group. As a Supply Officer in the U.S. Naval Reserve,
Lieutenant Wilson served on a fast attack nuclear submarine and as
a Naval Advisor to the Vietnamese Naval Supply Center
in Saigon. Mr. Wilson received his MBA from Harvard Business
School and his JD from Harvard Law School in 1976; he is a member
of the Bar in North Carolina. In 1968, he
received his AB in Economics from Yale University,
where he was elected to Phi Beta Kappa. Mr. Wilson is a member
of the Executive Committee of The Atlantis Group, a
member managed angel investor venture capital fund.
He is also a member of the Licensing Executives Society and the Association of Corporate Counsel.
|
 |
